Smoking is a leading cause of preventable disease and death.
Treatment and Intervention
This project seeks to develop knowledge about effective models of partnership between rural Aboriginal communities and researchers across a range of community-led programs delivered from 2012-2016, which aimed to reduce drug and alcohol-related harm.
This project will review the evidence for the medicinal use of cannabis and cannabinoid products for a number of key medical conditions.
Substance use among pregnant women is a significant public health issue. A range of adverse effects have been noted including increased risk of miscarriage and still birth, reduction in fetal growth, birth defects, developmental delay, growth retardation and neurological abnormalities.
Australian surveys of those with cannabis use disorder (CUD) reveal that general medical practitioners (GPs) are the preferred source of treatment as they are seen as trust worthy and confidential.
With NSW having the largest GLBT community in Australia, it is important that responses to the problems faced by these populations (including a higher risk of drug use and mental health problems) are informed by research evidence.
The monograph is an outcome of the Intergovernmental Committee on Drugs (IGCD) Fetal Alcohol Spectrum Disorder (FASD) Working Party.
The purpose of this project was to summarise what is known internationally, nationally and in NSW about unmet need and unmet demand for OTP in NSW and provide some initial estimates for NSW.
Substance use amongst adolescents (those in the age group of 10-19) is an important public health issue in many countries of the region.